Drugs / oral protein supplements
oral protein supplements
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06570174 | Jan 2021 → Jul 2022 | cholangiocarcinoma, neuroendocrine neoplasm, pancreatic intraductal papillary-mucinous neoplasm, solid pseudopapillary neoplasm of the pancreas | Yonsei University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | oral protein supplements | “oral protein supplements” NCT06570174 ↗ |
| Modality | Protein / enzyme biologic | “oral protein supplement” NCT06570174 ↗ |
| Route | Oral | “oral protein supplement” NCT06570174 ↗ |